Cargando…
Global coagulation assays in patients with diabetes mellitus
BACKGROUND: There is significant heterogeneity in the incidence and severity of diabetes‐associated vascular complications and there is no routine biomarker that accurately predicts these outcomes. This pilot study investigates the role of global coagulation assays in patients with diabetes mellitus...
Autores principales: | Lim, Hui Yin, Lui, Brandon, Tacey, Mark, Kwok, Anna, Varadarajan, Suresh, Donnan, Geoffrey, Nandurkar, Harshal, Ho, Prahlad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576266/ https://www.ncbi.nlm.nih.gov/pubmed/34765860 http://dx.doi.org/10.1002/rth2.12611 |
Ejemplares similares
-
Plasma Angiotensin Converting Enzyme 2 (ACE2) Activity in Healthy Controls and Patients with Cardiovascular Risk Factors and/or Disease
por: Lim, Hui Yin, et al.
Publicado: (2022) -
The Need for Individualized Risk Assessment in Cardiovascular Disease
por: Lim, Hui Yin, et al.
Publicado: (2022) -
Overall Hemostatic Potential Assay Detects Risk of Progression to Post-Thrombotic Syndrome in Anticoagulated Patients following Deep Vein Thrombosis
por: McLeod, Blake, et al.
Publicado: (2022) -
Overall haemostatic potential (OHP) assay can risk stratify for venous thromboembolism recurrence in anticoagulated patients
por: Wang, Julie, et al.
Publicado: (2022) -
Current challenges in the prevention and management of post-thrombotic syndrome—towards improved prevention
por: Wang, Julie, et al.
Publicado: (2023)